drugset / Trial / NCT01102114

A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation

NCT01102114

Phase 3 Completed 1000 enrolled Nabi Biopharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate NicVAX as an aid to smoking cessation for long term abstinence.

Timeline

Start
2010-03
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject NicVAX Vaccine

Indications

No indication recorded.